Company Filing History:
Years Active: 2015-2020
Title: Xuebin Qin: Innovator in Metabolic Pathways and Disease Treatment
Introduction
Xuebin Qin is a notable inventor based in Westwood, MA (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of metabolic pathways for disease treatment. With a total of 2 patents, his work has the potential to impact various therapeutic approaches.
Latest Patents
Xuebin Qin's latest patents include innovative methods and compositions aimed at treating diseases. One patent focuses on the modulation of NAD+ metabolic pathways, encompassing compositions and methods for regulating the kynurenine to tryptophan ratio, NAD+ level, and CD16 expression. This invention holds promise for the treatment of various diseases. Another patent features proteins, including an antibody that binds hCD59, which can prevent the independent induction of CDC and ADCC. This invention includes modifications that disrupt the interaction between the antibody and complement, showcasing his innovative approach to tackling proliferative and pathogenic diseases.
Career Highlights
Throughout his career, Xuebin Qin has worked with prestigious institutions such as Temple University and Harvard College. His research has contributed to advancements in understanding metabolic pathways and their implications for disease treatment.
Collaborations
Xuebin has collaborated with notable individuals in his field, including Jay F Rappaport and Stephani Velasquez. These collaborations have further enriched his research and innovation efforts.
Conclusion
Xuebin Qin's work in the modulation of metabolic pathways and disease treatment exemplifies the impact of innovative research in the biomedical field. His patents and collaborations highlight his commitment to advancing medical science and improving therapeutic strategies.